Dr. Anne MÃ¥nsson Kvarnhammar earned her PhD 2009 at Lund University, Sweden, working on the immune response in allergic rhinitis. This area was further pursued during a postdoc position at Karolinska institutet. In 2012, Dr. Kvarnhammar joined Novo Nordisk, Denmark, working with developing models to predict and reduce the clinical immunogenicity to biologics as well as novel tolerance concept. In February 2017, Dr. Kvarnhammar joined Alligator Bioscience. As Senior Scientist she is Scientific Lead for the ATOR-1144 and ATOR-1015 programs.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October
To sponsor or exhibit contact:
Derek Cavanagh
+44 (0)207 092 1297
derek.cavanagh@terrapinn.com
To speak:
Joan Shutt
+44 (0)207 092 1134
joan.shutt@terrapinn.com